Physician profile
Meagan Gates
NPI 1013543792
$1,121.46
in general payments reported to CMS, 2019-2025
19 companies · $67.05 in 2025
The $67.05 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $940 · 2022: $31.24 · 2024: $82.77 · 2025: $67.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $282.00 | 2021-2025 | Trelegy Ellipta |
| Abbvie INC. | $218.93 | 2021-2025 | |
| Bausch Health US, LLC | $87.86 | 2021 | |
| Galderma Laboratories, L.P. | $71.96 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $66.52 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $50.75 | 2021 | |
| Eisai INC. | $41.96 | 2021 | |
| Lilly USA, LLC | $40.62 | 2021 | |
| Novo Nordisk INC | $40.13 | 2021 | |
| Vanda Pharmaceuticals INC. | $35.28 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.25 | 2021 | |
| Endo Pharmaceuticals INC. | $24.60 | 2021 | |
| Astellas Pharma US INC | $23.67 | 2021 | |
| Hologic Sales and Service, LLC | $22.86 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.91 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.04 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.81 | 2021 | |
| Merck Sharp & Dohme LLC | $13.91 | 2021 | |
| Pfizer INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.